Physician profile
Xiao Li
NPI 1730122748
$694.10
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $63.82 · 2021: $11.11.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $166.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $59.54 | 2019 | |
| Novo Nordisk INC | $48.05 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $45.29 | 2019 | |
| Sanofi-Aventis U.S. LLC | $40.61 | 2019-2020 | |
| Lilly USA, LLC | $40.44 | 2019-2020 | |
| Pfizer INC. | $39.34 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $38.70 | 2019 | |
| Mylan Specialty L.P. | $30.06 | 2019 | |
| Eisai INC. | $28.98 | 2019 | |
| Hikma Pharmaceuticals USA | $14.88 | 2019 | |
| Amarin Pharma, INC. | $12.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.73 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.27 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiao Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.